Noncommercial US Funders’ Policies on Trial Registration, Access to Summary Results, and Individual Patient Data Availability
Open Access
- 4 January 2019
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 2 (1) , e187498
Abstract
Over the past 20 years,1 national and international initiatives have been launched to improve clinical trial registration and reporting.2-4 Incomplete information about existing research is an underlying cause of research waste5 and undermines credible, efficient production of research to support health care decision making.6 Trial registries afford the means to capture a minimum, structured information set from all ongoing and completed clinical trials in humans and to make these publicly accessible. Efforts in the United States have been greatly enhanced by the creation of ClinicalTrials.gov in 2000 by the National Institutes of Health (NIH), which expanded to incorporate results reporting in 2008; ClinicalTrials.gov currently houses approximately a quarter of a million trial records, representing about two-thirds of clinical trials registered globally.7Keywords
This publication has 15 references indexed in Scilit:
- Update on Trial Registration 11 Years after the ICMJE Policy Was EstablishedNew England Journal of Medicine, 2017
- Trial Reporting in ClinicalTrials.gov — The Final RuleNew England Journal of Medicine, 2016
- Toward a New Era of Trust and Transparency in Clinical TrialsJAMA, 2016
- Clinical Trials Registration and Results Information Submission. Final rule.2016
- How to Make More Published Research TruePLOS Medicine, 2014
- Increasing value and reducing waste: addressing inaccessible researchThe Lancet, 2014
- The Evolution of Trial Registries and Their Use to Assess the Clinical Trial EnterpriseJAMA, 2012
- Clinical Trial RegistrationJAMA, 2004
- From Science to PracticeJAMA, 1995
- From science to practice. Meta-analyses using individual patient data are neededJAMA, 1995